1. Home
  2. DAKT vs EVO Comparison

DAKT vs EVO Comparison

Compare DAKT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.79

Market Cap

944.7M

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
EVO
Founded
1968
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.7M
1.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
DAKT
EVO
Price
$20.79
$3.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
231.4K
47.1K
Earning Date
03-04-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$608,932,000.00
N/A
Revenue This Year
$12.06
$1.37
Revenue Next Year
$9.16
$10.05
P/E Ratio
$27.29
N/A
Revenue Growth
6.89
N/A
52 Week Low
$13.05
$2.31
52 Week High
$28.27
$4.42

Technical Indicators

Market Signals
Indicator
DAKT
EVO
Relative Strength Index (RSI) 59.01 56.03
Support Level $18.76 $2.88
Resistance Level $21.14 $3.75
Average True Range (ATR) 0.55 0.07
MACD 0.14 0.01
Stochastic Oscillator 89.72 89.58

Price Performance

Historical Comparison
DAKT
EVO

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: